Becker, J. C. and Ugurel, S. and Leiter-Stoppke, U. and Meier, F. and Gutzmer, R. and Haferkamp, S. and Zimmer, L. and Livingstone, E. and Eigentler, T. and Hauschild, A. and Kiecker, F. and Hassel, J. C. and Mohr, P. and Fluck, M. and Thomas, I. and Garzarolli, M. and Grimmelmann, I. and Drexler, K. and Eckhardt, S. and Schadendorf, D. (2022) Adjuvant immunotherapy with nivolumab (NIVO) versus observation in completely resected Merkel cell carcinoma (MCC): Disease-free survival (DFS) results from ADMEC-O, a randomized, open-label phase II trial. ANNALS OF ONCOLOGY, 33 (Suppl7). S903. ISSN 0923-7534, 1569-8041
Full text not available from this repository.
Official URL: https://www.sciencedirect.com/science/article/pii/...
| Item Type: | Article |
|---|---|
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Dermatologie und Venerologie |
| Depositing User: | Petra Gürster |
| Date Deposited: | 04 Jul 2024 10:02 |
| Last Modified: | 04 Jul 2024 10:02 |
| URI: | https://pred.uni-regensburg.de/id/eprint/58543 |
Actions (login required)
 |
View Item |
